Valeant Debacle is Bad News for Ackman, Ubben, Others

The healthcare stock fell so far on Wednesday that trading was briefly halted. But some hedge fund die-hards say the bloodbath is a buying opportunity.

bill-ackman-thumbnail.jpg
mike-pearson.jpg
Michael Pearson, Valeant Pharmaceuticals International
(Bloomberg)

This Valeant Pharmaceuticals International sell-off is starting to get ugly.

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Related